Serum T50 Predicts Cardiovascular Mortality in Individuals With Type 2 Diabetes: a Prospective Cohort Study
Source : https://pubmed.ncbi.nlm.nih.gov/38528373/
Serum T50 improves prediction of cardiovascular and all-cause mortality risk in individuals with T2D. Serum T50 may be useful for risk stratification and to guide therapeutic strategies aiming to reduce...
Serum T50 may be useful for risk stratification and to guide therapeutic strategies aiming to reduce CV mortality in type 2 diabetes.
Patients' Perceptions of Artificial Intelligence in a Deep Learning-Assisted Diabetic Retinopathy Screening Event: a Real-World Assessment
Source : https://pubmed.ncbi.nlm.nih.gov/38404014/
During an artificial intelligence (AI)-assisted diabetic retinopathy screening event, we performed a survey on patients´ perceptions on AI. Respondents were individuals with diabetes, mostly followed in primary healthcare with a...
Although nearly 50% of participants reported that they knew what artificial intelligence (AI) was, only 14% reported having good or expert knowledge of AI but most said they felt positive about it in health care.
Association Between Thyroid Autoimmunity and Bone Mineral Density in Patients With Type 2 Diabetes Mellitus: a Cross-Sectional Study
Source : https://pubmed.ncbi.nlm.nih.gov/38393508/
In T2DM patients, TPOAb and TGAb levels are negatively correlated with LS, FN and WB BMD, and TPOAb is an independent influencing factor for diabetic osteoporosis, and TPOAb has a...
In patients with T2D, thyroid autoimmunity positive and negative levels were negatively correlated with T-score and BMD, and thyroid autoimmunity positivity was an independent influencing factor for diabetic osteoporosis.
In this cohort study of 1229 individuals who participated in the Look AHEAD trial, incorporating high physical activity volume and weight loss was associated with a 61% of lower risk of adverse CV events.
Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: a Nationwide Population-Based Study
Source : https://pubmed.ncbi.nlm.nih.gov/38325629
In patients with type 2 diabetes initially diagnosed with DFC, SGLT2i are effective in significantly reducing the hospitalization for heart failure and MACE rates. SGLT2i lower the amputation rates, especially...
The amputation rates were lower in patients taking SGLT2 inhibitors without lower extremity amputation at the first diabetic foot complication and did not increase in those with a history of peripheral artery disease or lower extremity amputation.